<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30127288</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Synthesis and Evolution of Berberine Derivatives as a New Class of Antiviral Agents against Enterovirus 71 through the MEK/ERK Pathway and Autophagy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2084</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules23082084</ELocationID><Abstract><AbstractText>Taking berberine (BBR) as the lead, 23 new BBR derivatives were synthesized and examined for their antiviral activities against four different genotype enterovirus 71 (EV71) strains with a cytopathic effect (CPE) assay. Structure-activity relationship (SAR) studies indicated that introduction of a suitable substituent at the 9-position might be beneficial for potency. Among them, compound <b>2d</b> exhibited most potent activities with IC<sub>50</sub> values of 7.12&#x207b;14.8 &#x3bc;M, similar to that of BBR. The effect of <b>2d</b> was further confirmed in a dose-dependent manner both in RNA and protein level. The mechanism revealed that <b>2d</b> could inhibit the activation of MEK/ERK signaling pathway. Meanwhile, it could suppress the EV71-induced autophagy by activating AKT and inhibiting the phosphorylation of JNK and PI3KIII proteins. We consider BBR derivatives to be a new family of anti-EV71 agents through targeting host components, with an advantage of broad-spectrum anti-EV71 potency.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan-Xiang</ForeName><Initials>YX</Initials><Identifier Source="ORCID">0000-0001-9124-071X</Identifier><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. wangyanxiang@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. yolo2022@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hui-Qiang</ForeName><Initials>HQ</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. hq_wangimb@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiao-Qiang</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. xiaoqiangzhao2017@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. lutyliu@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying-Hong</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. liyinghong@imb.pumc.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Qing-Xuan</ForeName><Initials>QX</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. zqx50810793@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yu-Huan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. yuhuanlibj@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Dan-Qing</ForeName><Initials>DQ</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. songdanqingsdq@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0I8Y3P32UF</RegistryNumber><NameOfSubstance UI="D001599">Berberine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.12.2</RegistryNumber><NameOfSubstance UI="D048670">MAP Kinase Kinase 4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001599" MajorTopicYN="N">Berberine</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048670" MajorTopicYN="N">MAP Kinase Kinase 4</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MEK/ERK pathway</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">berberine</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">structure-activity relationship</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30127288</ArticleId><ArticleId IdType="pmc">PMC6222558</ArticleId><ArticleId IdType="doi">10.3390/molecules23082084</ArticleId><ArticleId IdType="pii">molecules23082084</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMinn P.C. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol. 2012;2:199&#x2013;205. doi: 10.1016/j.coviro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestri R., Bellino M., Landini L., Tasin L., Rizzoli L., Speziali L., Bauer P., Sicher M.C., Rech G., Girardelli C.R. Atypical presentation of enterovirus infection in adults: Outbreak of &#x201c;Hand, Foot, Mouth and Scalp disease&#x201d; in Northern Italy. J. Eur. Acad. Dermatol. Venereol. 2014;59:201&#x2013;203. doi: 10.1111/jdv.14507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.14507</ArticleId><ArticleId IdType="pubmed">28776768</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K.F., Chen L.L., Huang P.N., Shih S.R. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 2010;12:505&#x2013;510. doi: 10.1016/j.micinf.2010.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2010.03.006</ArticleId><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.Q., Li K., Ma L.L., Wu S., Hu J., Yan H.Y., Jiang J.D., Li Y.H. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol. J. 2017;14 doi: 10.1186/s12985-016-0674-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0674-4</ArticleId><ArticleId IdType="pmc">PMC5234143</ArticleId><ArticleId IdType="pubmed">28081706</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Lin T.Y., Hsu K.H., Huang Y.C., Lin K.L., Hsueh C., Shih S.R., Ning H.C., Hwang M.S., Wang H.S., et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682&#x2013;1686. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Li F.Q., Pan Z.Y., Wu Z.J., Wang Y.H., Cui Y.D. Activation of PI3K/Akt pathway limits JNK-mediated apoptosis during EV71 infection. Virus Res. 2014;192:74&#x2013;84. doi: 10.1016/j.virusres.2014.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.07.026</ArticleId><ArticleId IdType="pubmed">25116390</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.Q., Hu J., Yan H.Y., Wu S., Li Y.H. Corydaline inhibits enterovirus 71 replication by regulating COX-2 expression. J. Asian Nat. Prod. Res. 2017;19:1124&#x2013;1133. doi: 10.1080/10286020.2017.1386658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10286020.2017.1386658</ArticleId><ArticleId IdType="pubmed">29034730</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.X., Fu H.G., Li Y.H., Jiang J.D., Song D.Q. Synthesis and biological evaluation of 8-substituted berberine derivatives as novel anti-mycobacterial agents. Acta Pharm. Sin. B. 2012;2:581&#x2013;587. doi: 10.1016/j.apsb.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2012.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.X., Li Y.H., Li Y.H., Gao R.M., Wang H.Q., Liu Y.X., Gao L.M., Lu Q.N., Jiang J.D., Song D.Q. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors. Bioorg. Med. Chem. 2012;20:6552&#x2013;6558. doi: 10.1016/j.bmc.2012.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2012.09.029</ArticleId><ArticleId IdType="pubmed">21880491</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.X., Liu L., Zeng Q.X., Fan T.Y., Jiang J.D., Deng H.B., Song D.Q. Synthesis and identification of novel Berberine derivatives as potent inhibitors against TNF-&#x3b1;-induced NF-&#x3ba;B activation. Molecules. 2017;22:1257. doi: 10.3390/molecules22081257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules22081257</ArticleId><ArticleId IdType="pmc">PMC6152030</ArticleId><ArticleId IdType="pubmed">28749438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.X., Pang W.Q., Zeng Q.X., Deng Z.S., Fan T.Y., Jiang J.D., Deng H.B., Song D.Q. Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1. Eur. J. Med. Chem. 2018;143:1858&#x2013;1868. doi: 10.1016/j.ejmech.2017.10.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2017.10.078</ArticleId><ArticleId IdType="pubmed">29133053</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.X., Xiao C.L., Wang Y.X., Li Y.H., Yang Y.H., Li Y.B., Bi C.W., Gao L.M., Jiang J.D., Song D.Q. Synthesis, structure-activity relationship and in vitro anti-mycobacterial evaluation of 13-n-octylberberine derivatives. Eur. J. Med. Chem. 2012;52:151&#x2013;158. doi: 10.1016/j.ejmech.2012.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2012.03.012</ArticleId><ArticleId IdType="pubmed">22503208</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.H., Li Y., Yang P., Kong W.J., You X.F., Ren G., Deng H.B., Wang Y.M., Wang Y.X., Jiang J.D., et al. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine. Bioorg. Med. Chem. 2010;18:6422&#x2013;6428. doi: 10.1016/j.bmc.2010.06.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmc.2010.06.106</ArticleId><ArticleId IdType="pubmed">20673726</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.C., Kong X.B., Mai W.P., Sun G.C., Zhao S.Z. Synthesis and antimicrobial activity of 9-o-substituted palmatine derivatives. Indian J. Pharm. Sci. 2015;77:196&#x2013;201. doi: 10.4103/0250-474X.156588.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0250-474X.156588</ArticleId><ArticleId IdType="pmc">PMC4442469</ArticleId><ArticleId IdType="pubmed">26009653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Zhang H., Zhu M., Luo Z., Peng Y. MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71) Antivir. Res. 2012;93:110&#x2013;117. doi: 10.1016/j.antiviral.2011.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2011.11.001</ArticleId><ArticleId IdType="pubmed">22101247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C.Y., Wang P., Chen X.Q., Wang W., Jin Y. Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway. Antivir. Res. 2015;119:47&#x2013;56. doi: 10.1016/j.antiviral.2015.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.04.009</ArticleId><ArticleId IdType="pubmed">25912818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Zhang H., Xu F.R., Niu Y., Wu Y., Wang X., Peng Y.H., Sun J., Liang L., Xu P. Substituted 3-benzylcoumarins as allosteric MEK1 inhibitors: Design, synthesis and biological evaluation as antiviral agents. Molecules. 2013;18:6057&#x2013;6091. doi: 10.3390/molecules18056057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules18056057</ArticleId><ArticleId IdType="pmc">PMC6269873</ArticleId><ArticleId IdType="pubmed">23698055</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Hsieh H.L., Lee I.T., Yang C.M. Enterovirus 71 modulates a COX-2/PGE2/cAMP- dependent viral replication in human neuroblastoma cells: Role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. J. Cell. Biochem. 2011;112:559&#x2013;570. doi: 10.1002/jcb.22946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22946</ArticleId><ArticleId IdType="pmc">PMC7166325</ArticleId><ArticleId IdType="pubmed">21268077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Ding L.X., Deng J., Zhang H., Zhu M., Yi T., Liu J., Xu P., Lu F.M., Peng Y.H. Replication of EV71 was suppressed by MEK1/2 inhibitor U0126. Chin. J. Biochem. Mol. Biol. 2010;6:538&#x2013;545.</Citation></Reference><Reference><Citation>Zhu M., Duan H., Gao M., Zhang H., Peng Y. Both ERK1 and ERK2 are required for enterovirus 71 (EV71) efficient replication. Viruses. 2015;7:1344&#x2013;1356. doi: 10.3390/v7031344.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7031344</ArticleId><ArticleId IdType="pmc">PMC4379574</ArticleId><ArticleId IdType="pubmed">25803100</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.H., Hsieh H.L., Yang C.M. Enterovirus 71 induces COX-2 expression via MAPKs, NF-kappa B, and AP-1 in SK-N-SH cells: Role of PGE (2) in viral replication. Cell Signal. 2010;22:234&#x2013;246. doi: 10.1016/j.cellsig.2009.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2009.09.018</ArticleId><ArticleId IdType="pubmed">19800403</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W.F., Hou X.L., Peng H.J., Zhang L., Li Y.Y., Gu Z.W., Jiang Q.B., Shi M., Ji Y., Jiang J.T. MEK/ERK signaling pathway is required for enterovirus 71 replication in immature dendritic cells. Virol. J. 2014;11 doi: 10.1186/s12985-014-0227-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-014-0227-7</ArticleId><ArticleId IdType="pmc">PMC4304142</ArticleId><ArticleId IdType="pubmed">25548009</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.C., Chang C.L., Wang P.S., Sai Y.T., Liu H.S. Enterovirus 71-Induced autophagy detected in vitro and in vivo promotes viral replication. J. Med. Virol. 2009;81:1241&#x2013;1252. doi: 10.1002/jmv.21502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21502</ArticleId><ArticleId IdType="pmc">PMC7166624</ArticleId><ArticleId IdType="pubmed">19475621</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin F., Zhang Z.B. Progress in studies on JNK signaling pathway and autophagy. J. Cent. South Univ. 2015;40:1035&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">26408626</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng F.B., Qiu H.Y. Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis. Biomed. Pharmacother. 2018;102:1209&#x2013;1220. doi: 10.1016/j.biopha.2018.03.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.03.142</ArticleId><ArticleId IdType="pubmed">29710540</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>